gland pharma glp-1 capacity expansion capex Forbes India | Indian pharma's US exposure has shifted sharply since FY20, with most majors trimming reliance on America even as Washington weighs tariffs GLP-1 Receptor Agonist Market Growth
Pay in 4 interest-free payments of $5.82 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16

























